U.S. Markets closed

NovaBay Pharmaceuticals, Inc. (NBY)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
3.55+0.20 (+5.97%)
At close: 4:02PM EDT
People also watch
OPXAIMUCCYCCLPTNNAVB
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue11,8974,3811,054
Cost of Revenue2,4641,261486
Gross Profit9,4333,120568
Operating Expenses
Research Development1,3715,7289,483
Selling General and Administrative19,04418,5297,989
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-10,982-21,137-16,904
Income from Continuing Operations
Total Other Income/Expenses Net-2,1672,1661,712
Earnings Before Interest and Taxes-13,149-18,971-15,192
Interest Expense---
Income Before Tax-13,149-18,971-15,192
Income Tax Expense222
Minority Interest---
Net Income From Continuing Ops-13,151-18,973-15,194
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,151-18,973-15,194
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-13,151-18,973-15,194